Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021

Same author

Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response.

Current oncology (Toronto, Ont.)·2019

Same author

[The importance of neuropsychological assessment for forensic psychiatric evaluations of defendants].

Tijdschrift voor psychiatrie·2016

Same author

Knowledge, attitudes and practices towards blood donation in Barbados.

Transfusion medicine (Oxford, England)·2016

Same author

Reciprocating instruments in endodontics: a review of the literature.

SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging·2015

Same author

Factors influencing the life span of modern root canal instruments--a literature review.

SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging·2013

Search research articles

Related Experiment Video

Updated: Jan 9, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

[A brief test for dementia screening: the ADS3].

J Lindeboom¹, C Jonker

¹Afdeling Medische Psychologie, VU-Ziekenhuis, Valeriuskliniek, Amsterdam.

Tijdschrift Voor Gerontologie En Geriatrie

|June 1, 1988

Summary

The ADS3 is a brief screening tool assessing Visual Memory, Orientation, and Fluency. It demonstrates satisfactory validity and reliability for its intended use.

Area of Science:

Neuropsychology
Cognitive Assessment

Background:

Short screening tests are valuable for initial cognitive evaluations.
Assessing cognitive functions like memory, orientation, and fluency is crucial in various clinical settings.

Purpose of the Study:

To evaluate the psychometric properties of the ADS3, a short screening test.
To determine the validity and reliability of the ADS3 for cognitive assessment.

Main Methods:

The study involved the administration of the ADS3, which includes subtests for Visual Memory, Orientation, and Fluency.
Psychometric analyses were conducted to assess validity and reliability.

Main Results:

The ADS3 demonstrated satisfactory validity and reliability within the scope of a short screening test.

More Related Videos

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Related Experiment Videos

Last Updated: Jan 9, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

The test was designed with measures to prevent misuse.

Conclusions:

The ADS3 is a suitable short screening test for evaluating Visual Memory, Orientation, and Fluency.
The satisfactory psychometric properties support its use in cognitive screening.